Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.42 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.34 |
| ▸ | CACNA1I | Q9P0X4 | 1/20 | 0.34 |
| ▸ | CCR2 | P41597 | 1/20 | 0.34 |
| ▸ | RAD52 | P43351 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15709382 | 0.98 | SIGMAR1 (0.43) | SIGMAR1FOLH1ALDH1A1NPC1RAB9A | |
| SCHEMBL20145720 | 0.90 | SIGMAR1 (0.39) | SIGMAR1FOLH1ALDH1A1NPC1RAB9A | |
| SCHEMBL15047614 | 0.86 | KDM4E (0.48) | SIGMAR1SMN1; SMN2ALDH1A1L3MBTL1KCNH2 | |
| SCHEMBL15906364 | 0.84 | OPRD1 (0.40) | FOLH1GAASMN1; SMN2ALDH1A1L3MBTL1 | |
| SCHEMBL15709381 | 0.83 | KDM4E (0.47) | SIGMAR1SMN1; SMN2ALDH1A1L3MBTL1KCNH2 | |
| SCHEMBL20193720 | 0.82 | FOLH1 (0.38) | SIGMAR1FOLH1GAASMN1; SMN2ALDH1A1 | |
| SCHEMBL15709429 | 0.82 | FOLH1 (0.40) | FOLH1ALDH1A1L3MBTL1CYP2D6KCNH2 | |
| SCHEMBL1079200 | 0.81 | FOLH1 (0.45) | SIGMAR1FOLH1 | |
| SCHEMBL5864632 | 0.81 | FOLH1 (0.45) | SIGMAR1FOLH1 | |
| SCHEMBL1996255 | 0.81 | FOLH1 (0.45) | SIGMAR1FOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140314670-A1 | CLICKED SOMATOSTATIN CONJUGATED ANALOGS FOR BIOLOGICAL APPLICATIONS | UNIVERSITE DE CERGY PONTOISE (FR) | 2014-10-23 | — | — | US | disclosed |
| WO-2013088395-A1 | CLICKED SOMATOSTATIN CONJUGATED ANALOGS FOR BIOLOGICAL APPLICATIONS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2013-06-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140314670-A1 | CLICKED SOMATOSTATIN CONJUGATED ANALOGS FOR BIOLOGICAL APPLICATIONS | SSTR4, SSTR3, SSTR2 | SIGMAR1 352/4885FOLH1 638/4885GAA 1500/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.